156 related articles for article (PubMed ID: 32856050)
1. Results From 2 Cohort Studies in Central Africa Show That Clearance of Wuchereria bancrofti Infection After Repeated Rounds of Mass Drug Administration With Albendazole Alone Is Closely Linked to Individual Adherence.
Campillo JT; Awaca-Uvon NP; Missamou F; Tambwe JP; Kuyangisa-Simuna G; Weil GJ; Louya F; Boussinesq M; Pion SDS; Chesnais CB
Clin Infect Dis; 2021 Jul; 73(1):e176-e183. PubMed ID: 32856050
[TBL] [Abstract][Full Text] [Related]
2. The impact of four years of semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: A community-based study in the Democratic Republic of the Congo.
Pion SDS; Chesnais CB; Awaca-Uvon NP; Vlaminck J; Abdou A; Kunyu-Shako B; Kuyangisa Simuna G; Tambwe JP; Weil GJ; Boussinesq M
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008322. PubMed ID: 32574160
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study.
Fimbo AM; Mnkugwe RH; Mlugu EM; Kunambi PP; Malishee A; Minzi OMS; Kamuhabwa AAR; Aklillu E
Infect Dis Poverty; 2024 Jun; 13(1):44. PubMed ID: 38867265
[TBL] [Abstract][Full Text] [Related]
4. The impact of two semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo.
Pion SD; Chesnais CB; Bopda J; Louya F; Fischer PU; Majewski AC; Weil GJ; Boussinesq M; Missamou F
Am J Trop Med Hyg; 2015 May; 92(5):959-66. PubMed ID: 25758650
[TBL] [Abstract][Full Text] [Related]
5. A strong effect of individual compliance with mass drug administration for lymphatic filariasis on sustained clearance of soil-transmitted helminth infections.
Campillo JT; Awaca-Uvon NP; Tambwe JP; Kuyangisa-Simuna G; Vlaminck J; Weil GJ; Boussinesq M; Chesnais CB; Pion SDS
Parasit Vectors; 2021 Jun; 14(1):310. PubMed ID: 34103096
[TBL] [Abstract][Full Text] [Related]
6. How Thailand eliminated lymphatic filariasis as a public health problem.
Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania.
Lupenza ET; Gasarasi DB; Minzi OM
PLoS One; 2022; 17(1):e0262693. PubMed ID: 35045109
[TBL] [Abstract][Full Text] [Related]
8. An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
Jambulingam P; Kuttiatt VS; Krishnamoorthy K; Subramanian S; Srividya A; Raju HKK; Rahi M; Somani RK; Suryaprakash MK; Dwivedi GP; Weil GJ
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009069. PubMed ID: 33591979
[TBL] [Abstract][Full Text] [Related]
9. Semiannual Treatment of Albendazole Alone is Efficacious for Treatment of Lymphatic Filariasis: A Randomized Open-label Trial in Cote d'Ivoire.
Ouattara AF; Bjerum CM; Aboulaye M; Kouadio O; Marius VK; Andersen B; Lew D; Goss CW; Weil GJ; Koudou BG; King CL
Clin Infect Dis; 2022 Jul; 74(12):2200-2208. PubMed ID: 33674871
[TBL] [Abstract][Full Text] [Related]
10. Assessment of microfilaremia in 'hotspots' of four lymphatic filariasis endemic districts of Nepal during post-MDA surveillance.
Mehta PK; Maharjan M
PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011932. PubMed ID: 38295107
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.
Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Thakur PA; Gupta A; Ingole NS; Lazdins-Helds JK
Parasitol Res; 2017 Oct; 116(10):2683-2694. PubMed ID: 28785847
[TBL] [Abstract][Full Text] [Related]
12. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
Rao RU; Samarasekera SD; Nagodavithana KC; Punchihewa MW; Ranasinghe USB; Weil GJ
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007365. PubMed ID: 31009482
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis.
El Setouhy M; Ramzy RM; Ahmed ES; Kandil AM; Hussain O; Farid HA; Helmy H; Weil GJ
Am J Trop Med Hyg; 2004 Feb; 70(2):191-6. PubMed ID: 14993632
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.
Rao RU; Nagodavithana KC; Samarasekera SD; Wijegunawardana AD; Premakumara WD; Perera SN; Settinayake S; Miller JP; Weil GJ
PLoS Negl Trop Dis; 2014; 8(11):e3281. PubMed ID: 25393404
[TBL] [Abstract][Full Text] [Related]
17. The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.
El-Setouhy M; Abd Elaziz KM; Helmy H; Farid HA; Kamal HA; Ramzy RM; Shannon WD; Weil GJ
Am J Trop Med Hyg; 2007 Dec; 77(6):1069-73. PubMed ID: 18165524
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
Tavul L; Laman M; Howard C; Kotty B; Samuel A; Bjerum C; O'Brian K; Kumai S; Amuga M; Lorry L; Kerry Z; Kualawi M; Karl S; Makita L; John LN; Bieb S; Wangi J; Weil GJ; Goss CW; Tisch DJ; Pomat W; King CL; Robinson LJ
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010096. PubMed ID: 35139070
[TBL] [Abstract][Full Text] [Related]
19. Impact of Semi-Annual Albendazole on Lymphatic Filariasis and Soil-Transmitted Helminth Infection: Parasitological Assessment after 14 Rounds of Community Treatment.
Pion SDS; Chesnais CB; Weil GJ; Louya F; Boussinesq M; Missamou F
Am J Trop Med Hyg; 2021 Dec; 106(2):729-731. PubMed ID: 34929673
[TBL] [Abstract][Full Text] [Related]
20. Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial.
Hardy M; Samuela J; Kama M; Tuicakau M; Romani L; Whitfeld MJ; King CL; Weil GJ; Grobler AC; Robinson LJ; Kaldor JM; Steer AC
Clin Infect Dis; 2021 Sep; 73(6):994-1002. PubMed ID: 33728462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]